Variation in phenolic acids and antibacterial attributes of peel extracts from ripe and unripe [Citrus limon (L.) Osbeck] fruit
This study reveals variation in phenolic acids and antimicrobial attributes of peel extracts from ripe and unripe lisbon lemon [ Citrus limon (L.) Osbeck] fruit. Total phenolic contents in ripened lemon peels were significantly ( p < 0.05) higher (138.66–344.33 GAE mg/g DW) than the unripen lemo...
Saved in:
Published in | Journal of food measurement & characterization Vol. 14; no. 3; pp. 1325 - 1332 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.06.2020
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This study reveals variation in phenolic acids and antimicrobial attributes of peel extracts from ripe and unripe lisbon lemon [
Citrus limon
(L.) Osbeck] fruit. Total phenolic contents in ripened lemon peels were significantly (
p
< 0.05) higher (138.66–344.33 GAE mg/g DW) than the unripen lemon peel (122.33–277.10 GAE mg/g DW). The total amount of individual phenolic acids as analyzed by RP-HPLC in unripe and ripened peels ranged from 3.8 ± 2.2 to 1453.6 ± 66.4 and 3.4 ± 1.8 to 1772 ± 64 mg/kg, respectively with gallic, caffeic, cinnamic, syringic, vanilic, vanillin,
p
-coumaric,
m
-coumaric and
o
-coumaric acids as the main compounds detected. As per disk diffusion measurement, different solvent (methanol, ethyl acetate and chloroform) extracts from ripened and unripe lemon peel exhibited considerable antimicrobial activity against four bacterial strains including
Salmonella typhimurium, Bacillus subtilus, Escherichia coli
and
Staphylococcus aureus
with 50% chloroform extracts having the best potential. The composition of phenolics and antimicrobial activity of tested peels varied notably in relation to extraction solvents and fruit maturity stages. Overall, the present results support potential uses of limon peels as a natural source of high-value phenolics/antimicrobial agents for nutra-pharmaceutical developments. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 2193-4126 2193-4134 |
DOI: | 10.1007/s11694-020-00380-w |